Blackrock had only 4.8MM shares as of 9/30/14 and now they have doubled it to 9.6MM shares. Add FMC's 10MM shares and NTC's 12.5MM shares, they own almost a third of the company between themselves! Wait till we hear from Vanguard (5MM), Tahithromos (5MM), Credit Suisse (4.5MM) Barclays (3MM), Meditor (3MM) and Sarissa (2.5MM). The institutions are going bananas with the buying while the free float vanishes.
I can't explain the 3 day drop of 65 cents, especially with good news from today's presentation and the recent institutional buying but I am not concerned. I may even dump some of my other stocks and get more if the MMs take it even lower. It is already trading below cash at hand. I will follow the big boys on this one. Get it to a nice round number like 100K shares if I can...
Sentiment: Strong Buy
25% is huge (decent trial sample size too) when your odds of surviving is 5% or less otherwise. 5 x the chance for survival - are you kidding me? And the fact that this condition is relatively rare, the chance of a media circus on an incorrect approval is very low. The FDA obviously sees something here and hence the granting of an early BLA filing. Besides, you need to ask this question to someone who is suffering from bladder cancer and not the average Joe looking at this as an investment down here. I am the latter category!
Not that you are going to agree to anything I say but how often do you hear the blue chips go and buy some tiny outfit with some futuristic, unproven product? They are only concerned about smaller competitors that are starting to kick their butt (buy them out), big competitors (merge with them) or their own R&D to stay ahead of the competition. They rather pay a billion for a new product with proven demand than taking shots with mom and pop operations. They should but they don't. Anyway, there is a visionary named Joe who thinks this has some promise. So there is that big boy 'interest' that you are concerned about. If it doesn't pan out, he doesn't care. But if it does, that's another cap in his feather. I am not even betting this will be a home run. Just the act of taking this to market will be a 400-1000% run from here. If you remember, it ran from these levels to 0.008 (1000%) on that prospect last year....
rup, you sure know the lives of the rich and famous. Congrats! I will follow the actions of the maverick fund manager. BTW, there is also the little fact that NTC holds only 12.5MM shares of the total 70+MM held by institutions. So the inaction of others (like not selling for a loss last year) also speaks volumes in my book. And there are the milestone payments ($400 million?) , royalties, increasing revenues, high short ratio, $300M in the bank and AUXL's marketing. Please stick to your agenda and I shall stick to mine. I bought more just now to bring my cost average to Tuesday's open (day before yesterday).
No worries. You and I would do what you described but not a billion dollar hedge fund. They are not new to this company. They watched as this got killed 70% last year on increasing sales and waited only till the new year to start adding to their big loss. They have a very good idea what will happen in 2015 and are positioning themselves accordingly. Like I said, most of their holdings are sitting near 52 week highs. This is the odd ball and instead of cutting and running, they are adding aggressively. I might do the same today as this drop of 55 cents in a couple of days, on lower than average volume, is presenting a nice opportunity...
Thanks for your insight as a cancer victim/survivor. I hope you recover fully from this terrible condition. I need to start placing filters to read anything of value on this board. Amidst the name calling and subjectivity, there is a lot of valuable information from some long timers here. Keep it coming....
Oh and why would a billionaire go around tooting his horn that he has $100K in a start up? I don't know how much he has but I am trying to make a point here. The whole company is only valued at $900K! Now, if his effort is rewarded with the BCI device becoming the next big thing or even just a money making fad, there will be reports on how smart he was to catch it in its infancy and make a quick killing - like we don't know that already. If it is a bust, he moves on with hardly a notice. Also, why bring awareness to others who might just swallow the company for a few millions by opening your mouth, especially is you are a big kahuna like Joe? It was in the company's interest to let its shareholders know about Joe, to bring legitimacy to the company. Don't be too worried about Joe (I am telling others as I know what your position is) - he usually does what he says and we will soon see whether it bears fruit or not.
I paid $9500 for 10MM shares. If that means I am mega rich, so be it. BTW, I have more than 20 x that in another stock. Anyway, coming back to Mr. Abrams. It is quite simple to check that fact online. Just Google "joe abrams mind solutions". Then go to the Bloomberg Businessweek link and look at the full profile of said Joseph W. Abrams. Of his 17 worldwide affiliations, here is one you might be interested in:
"He has been a Member of Board of Advisors at Mind Solutions, Inc. since May 15, 2014....."
Simple. Welcome to the age of the internet....
Reverse splitting to up list is considered a positive step in the eyes of investors. It only has a negative connotation if it is to keep a listing or to dilute the shareholders to oblivion. Institutions will join as shareholders and the company can raise money much more easily with no toxic side effects. It will probably be a 1:25 RS. Looking forward to it later this year.
Thanks for the wishes. Got my other 5MM at 0.0009 just now. Now, time to wait for the next cycle of events. Last one took it to 0.008. I think the next one will go to at least half of that (0.004) and up from there if they are able to get decent sales. It hasn't been dis-proven that Joe Abrams is not on their BOD or that they don't have enough funds to take this to market. They already mentioned no reverse split or dilution before commercialization.
The Company's total liabilities and shareholders' equity at September 30, 2014 is $33.5 million, the same as at June 30, 2014.
The Company's consolidated cash flow used in operations for the quarter ended September 30, 2014 was $2.8 million, as compared to cash used in operations of $4.7 million in Q1, Fiscal 2014. The average monthly burn rate, based on cash used in operations, was approximately $0.9 million, and approximately $0.6 million before changes in non-cash working capital. This compares to $1.6 million and $1.3 million respectively for the same quarter in Fiscal 2014.
Administration expenses for continuing operations were $1.2 million in the first quarter of Fiscal 2015, as compared to $1.3 million in the first quarter of Fiscal 2014. The decrease reflects the Company's cost reduction efforts of about $0.7 million that started in Fiscal 2014, offset by reclassification of certain administrative expenses previously directed to support other operations in the area of research that have now been discontinued. Property management expenses were $0.4 million in Q1, Fiscal 2015, as compared to nil in Q1, Fiscal 2014. Marketing and selling expenses were nil in the first quarter of Fiscal 2015, as compared to $0.2 million in Q1, Fiscal 2014.
"Shareholders will note a substantial drop in financial expenses in this quarter," said Mr. Brian Ford, Chief Financial Officer of Bioniche. "Such expenses reduced by 85% - from $2.5 million in Q1, Fiscal 2014 to $0.4 million in Q1, Fiscal 2015. Proceeds from the sale of the Company's Animal Health business unit in April, 2014 allowed the Company to repay $50.3 million of high-cost secured and unsecured debt by the end of Fiscal 2014, resulting in significantly reduced financial expenses in the first quarter of Fiscal 2015."
Patients with high risk recurrences after bacillus Calmette-Guérin failure have limited options. We performed an open label study to evaluate the efficacy and safety of intravesical MCNA in this setting.
Materials and Methods
Patients were treated intravesically with 8 mg MCNA weekly for 6 weeks followed by 3 weekly instillations at months 3, 6, 12, 18 and 24. Cystoscopy and cytology were performed every 3 months for 2 years with mandatory biopsy at 6 months and as clinically indicated thereafter. The primary efficacy end point was the disease-free survival rate at 1 year.
A total of 129 patients were enrolled in study, including 91 with carcinoma in situ with or without papillary disease and 38 with papillary only tumors. Most patients had high risk disease. A total of 107 cases were bacillus Calmette-Guérin refractory and 2 or more prior bacillus Calmette-Guérin induction courses had been given in 68. Median followup in all patients was 34.7 months. The overall disease-free survival rate was 25.0% at 1 year and 19.0% at 2 years. In patients with papillary only tumors the disease-free survival rate was 35.1% and 32.2% at 1 and 2 years, respectively. The median disease-free duration in the 30 responders was 32.7 months. The progression-free survival rate was 87.3%, 79.8% and 77.7% at 1, 2 and 3 years, respectively, with a progression event in 28 patients. MCNA was well tolerated and few adverse events led to treatment discontinuation.
Intravesical MCNA achieved significant activity in patients at high risk with nonmuscle invasive bladder cancer in whom bacillus Calmette-Guérin treatment failed, especially those with papillary only tumors and those with bacillus Calmette-Guérin relapse. A durable response was seen, particularly in patients with a response at 1 year. MCNA offers an option for patients who are not candidates for or who refuse cystectomy.
jess, you are within your rights to share your views like anyone else here. Why do you think this company is a scam? Could you provide any evidence? I'd like to hear that side although I am long. Want to make an informed decision before I invest a lot more. It looks like you are simply #$%$ with the spamming and not the company per se? On the other hand, there is a lot of public information that this company has a promising treatment in Ph III and is getting ready for FDA submission. They also have not diluted shareholders to oblivion like so many other OTC stocks.
As promised, I am starting to pick up at 0.001. Put in a 5MM share order today and it filled in small lots of 100K each time, before the ASK moved up. Got 3.6MM shares so far. Will get 10MM shares to bring my average down to 0.0014. It should test 0.003-4 once the devices go on sale. Also will be nice to test it out if they actually do follow through on their promise to gift these to their shareholders. I am not optimistic about wild sales volumes but it could be a fad for a year since it is so different from anything that is out there. The key is to have some exciting games. Nobody wants to be exploding a dumpster with their mind - LOL!
I am assuming that means short more? Please be my guest. And get your buddies to do so as well. More the merrier - LOL!
I don't think so. It has been a controlled rise, which does not portray a significant short covering period. In fact, the gains for 2015 were wiped out yesterday and there might have been some additional shorting. I also think NTC bought before market close . If NTC takes its total position to around 16MM shares (+/- 1 MM), then my theory holds water. I am not concerned with the gyrations anymore since we have major support from a billionaire, healthcare hedge fund. It is just a matter of when and not if, that we get a short squeeze to $10 this year.
Yes, I noticed that in the Nov news release. The recent increase in volume is nice to see but I am not sure if it is the start of the slow run to the BLA submission or the result of the recent message board spamming (through which I came on board!). There seems to be some decent amount of shares for sale at the 20 cent level as I got my 50K shares almost immediately yesterday. I was expecting a 2 day fill period with such a low daily volume. It could breakout suddenly one fine day once the supply is gone. I will keep nibbling once every week to build a nice position here by March...
Thanks. Maybe this will be the next big Canadian company to take the US market by storm (like Blackberry and Nortel did during the dotcom boom). OK, not to that level, but a 20-40 bagger in 1-2 years is nothing to sneeze at. I'll start researching more and providing my own DD as I increase my position here.